Psomagen, Inc. Logo

Psomagen, Inc.

A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.

950200 | KO

Overview

Corporate Details

ISIN(s):
KR8840150005
LEI:
Country:
United States of America
Address:
City of Wilmington, County of New Castle, State of Delaware, Corporation Trust Cen, Wilmington
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Psomagen, Inc. is a contract research organization (CRO) providing comprehensive multiomics services and data analysis to scientists, clinicians, and researchers in the academic, biotechnology, and pharmaceutical sectors. Formerly Macrogen USA, the company offers a full suite of services, including genomics, epigenomics, proteomics, transcriptomics, and bioinformatics. It leverages cutting-edge technologies such as Next-Generation Sequencing (NGS), Third-Generation Sequencing, spatial biology, and cell line authentication. Psomagen operates multiple CLIA-certified and CAP-accredited laboratories across the United States, emphasizing data quality, security, and a collaborative client service model to make advanced biological analysis both accessible and affordable.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-08-13 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 10.2 KB
2025-06-13 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.7 MB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.7 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.6 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 28.6 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.2 MB
2025-03-21 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 346.5 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 14.2 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 209.4 KB
2025-02-14 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 12.8 KB
2025-01-17 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 15.7 KB
2025-01-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.3 KB
2025-01-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB

Automate Your Workflow. Get a real-time feed of all Psomagen, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Psomagen, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Psomagen, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR

Talk to a Data Expert

Have a question? We'll get back to you promptly.